Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2011 Mar 1;17(10):1460–1471. doi: 10.1016/j.bbmt.2011.02.001

Table 4.

T-cell response to CMV: there was a strong association between recipient CMV reactivation and development of a CMV-specific T-cell response.

N Tested According to Recipient
Serostatus & CMV Reactivation
Positive T-cell Response
to CMV /
First Time Detected
Post-Transplant
P value
CMV sero-negative
(N = 27)
2 (7%) /
Days 180 & 270.
P <
0.0001
CMV sero-positive,
no reactivation
(N = 12)
6 (50%) /
Days 60 (n = 2), 120 (n =
2), & 270 (n = 2)
CMV sero-positive,
reactivation
(N = 19)
15 (79%) /
Days 60 (n = 3), 120 (n =
7), 180 (n = 2), 270 (n =
1), & 1 year (n = 2).

Abbreviations: CMV, cytomegalovirus.